T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 4, 2007, Pages 415-420

  Huang, Tiao Lai ^a   Lee, Chien Te ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cytokine; IL 1 ; IL 10; Major depression; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS OF COVARIANCE; ANALYTIC METHOD; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; PHENOTYPE; SUICIDE ATTEMPT; TH1 CELL; TH2 CELL;

ACUTE DISEASE; ADULT; BODY MASS INDEX; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; SEX CHARACTERISTICS; TAIWAN; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347407667     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01686.x     Document Type: Article

References (45)

1. Maes M, Bosmans E, Suy E, DeJonckheere C, Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 1991 84 : 379 386.
2. Maes M, Wauters A, Neels H et al. Total serum protein and serum protein fractions in depression: Relationships to depressive symptoms and glucocorticoid activity. J. Affect. Disord. 1995 34 : 61 69.
3. Maes M, Delange J, Ranjan R et al. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psychiatry Res. 1997 66 : 1 11.
4. Maes M, De Vos N, Demedts P, Annick W, Neels H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J. Affect. Disord. 1999 56 : 189 194.
5. Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J. Affect. Disord. 1994 30 : 283 288.
6. Sluzewska A, Rybakowski J, Bosmans E et al. Indicators of immune activation in major depression. Psychiatry Res. 1996 64 : 161 167.
7. Huang TL. Lower serum albumin levels in patients with mood disorders. Chang Gung Med. J. 2002 25 : 509 513.
8. Huang TL, Lin FC. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar I disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 370 372.
9. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukine-6. Immunol. Today 1990 170 : 443 449.
10. Seidel A, Arolt V, Hunstriger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 1995 41 : 534 538.
11. Huang TL, Chen JF. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis and inflammation/immunity. Adv. Clin. Chem. 2005 39 : 81 105.
12. Smith RS. The macrophage theory of depression. Med. Hypotheses 1991 35 : 298 306 (Erratum in Med. Hypotheses 1991; 36: 178).
13. Kronfol Z, Remick DG. Cytokines and the brain: Implications for clinical psychiatry. Am. J. Psychiatry 2000 157 : 683 694.
14. Leonard B. Stress, depression and the activation of the immune system. World J. Biol. Psychiatry 2000 1 : 17 25.
15. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005 29 : 201 217.
16. Myint AM, Leonard BE, Steinbusch HWM, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J. Affect. Disord. 2005 88 : 167 173.
17. Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N.Y. Acad. Sci. 2006 1069 : 62 76.
18. Pavon L, Sandoval-Lopez G, Eugenia Hernandez M et al. Th2 cytokine response in major depressive disorder patients before treatment. J. Neuroimmunol. 2006 172 : 156 165.
19. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989 7 : 145 173.
20. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998 8 : 275 283.
21. Liew FY. TH1 and TH2 cells: A historical perspective. Nat. Rev. Immunol. 2001 2 : 55 60.
22. Maes M, Smith RS. Fatty acids, cytokines and major depression. Biol. Psychiatry 1998 43 : 313 314.
23. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J. Clin. Psychopharmacol. 2001 21 : 199 206.
24. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J. Affect. Disord. 2001 63 : 171 178.
25. Nakano Y, Nakamura S, Hirata M et al. Immune function and lifestyle of taxi drivers in Japan. Ind. Health 1998 36 : 32 39.
26. Marshall GD, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ. Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav. Immun. 1998 12 : 297 307.
27. Corcos M, Guilbaud O, Paterniti S et al. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: Preliminary findings. Psychoneuroendocrinology 2004 29 : 686 691.
28. Swain SL, Huston G, Tonkonogy S, Weinberg AD. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 1991 147 : 2991 3000.
29. Schmitt E, Hoehn P, Heuls C et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interteukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 1994 24 : 793 798.
30. Rothermundt M, Arolt V, Peters M et al. Inflammatory markers in major depression and melancholia. J. Affect. Disord. 2001 63 : 93 102.
31. Rothermundt M, Arolt V, Fenker J et al. Different immune patterns in melancholic and non-melancholic major depression. Eur. Arch. Psychiatry Clin. Neurosci. 2001 251 : 90 97.
32. Kaestner F, Hettich M, Peters M et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J. Affect. Disord. 2005 87 : 305 311.
33. Fisrt MB, Spitzer RL, Gibbon M, Williams JBW. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). American Psychiatric Press, Washington, DC, 1997.
34. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960 23 : 56 62.
35. Nishizawa Y, Shoji T, Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J. Ren. Nutr. 2006 16 : 241 244.
36. Erten Y, Tulmac M, Derici U et al. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients. Ren. Fail. 2005 27 : 581 589.
37. Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 2006 354 : 697 708.
38. Yang CM, Hsieh HL, Lee CW. Intracellular signaling mechanism underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 2005 28 : 813 823.
39. Tracey KJ, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and the therapeutic target. Annu. Rev. Med. 1994 45 : 491 503.
40. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 1990 40 : 1735 1739.
41. Sheng JG, Boop FA, Mrak RE, Griffin WS. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity. J. Neurochem. 1994 63 : 1872 1879.
42. Simen BB, Duman CH, Simen AA, Duman RS. TNFα signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006 59 : 775 785.
43. Leonard BE. The HPA and immune axes in stress: The involvement of the serotonergic system. Eur. Psychiatry 2005 3 : S302 S306.
44. Weiner HL. Oral tolerance: Immune mechanisms and the generation of Th-3 type TGF-beta-secreting regulatory cells. Microbes Infect. 2001 3 : 947 954.
45. Marques-Deak AH, Neto FL, Dominguez WV et al. Cytokine profiles in women with different subtypes of major depressive disorder. J. Psychiatr. Res. 2007 41 : 152 159.